<SEC-DOCUMENT>0001104659-20-059726-index.html : 20200512
<SEC-HEADER>0001104659-20-059726.hdr.sgml : 20200512
<ACCEPTANCE-DATETIME>20200511183212
ACCESSION NUMBER:		0001104659-20-059726
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200511
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200512
DATE AS OF CHANGE:		20200511

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CASI Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0000895051
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				581959440
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-20713
		FILM NUMBER:		20866459

	BUSINESS ADDRESS:	
		STREET 1:		9620 MEDICAL CENTER DR
		STREET 2:		STE 300
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		240-864-2600

	MAIL ADDRESS:	
		STREET 1:		9620 MEDICAL CENTER DR
		STREET 2:		STE 300
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ENTREMED INC
		DATE OF NAME CHANGE:	19960415
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2019030-1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
Document 1 - file: tm2019030-1_8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2019030d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
Document 2 - file: tm2019030d1_ex99-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: image_001.jpg

</DOCUMENT>
</SEC-DOCUMENT>